Passa al contenuto

Measuring Expression of Cytokines in Immune Cells During Infection or Inflammation

Introduction

Cytokines are pivotal signalling molecules produced by immune cells and other tissue-resident cells during infection, inflammation, tissue injury and repair. By regulating cell activation, proliferation, migration and inter-cellular communication, cytokines shape the outcome of immune responses. Thus, the measurement of cytokine expression in immune cells is foundational in immunology research, infection biology, inflammation studies, biomarker discovery and drug development. Monitoring cytokine expression enables insights into immune activation, regulatory checkpoints, therapeutic responses and disease progression.

What Are Cytokines?

Cytokines are small secreted (or sometimes membrane-bound) proteins or glycoproteins produced primarily by immune cells (such as macrophages, dendritic cells, T cells, B cells, NK cells) and also by non-immune cells (endothelial, epithelial, fibroblasts) in response to stimuli. They signal via autocrine, paracrine or endocrine mechanisms to regulate immune and non-immune processes.

Major cytokine families include:

  • Interleukins (IL-2, IL-4, IL-6, IL-10, IL-17, etc.)
  • Interferons (IFN-γ, IFN-α/β)
  • Tumour necrosis factors (TNF-α)
  • Chemokines (CCL2/MCP-1, CXCL8/IL-8)
  • Growth / colony-stimulating factors (GM-CSF, M-CSF)
  • TGF-β family (immune regulation, tissue repair)

When infection or inflammation occurs, cytokines orchestrate the innate immune response (e.g., macrophage activation, neutrophil recruitment), drive adaptive immunity (T cell differentiation, B cell activation), regulate resolution of inflammation and influence tissue-repair or fibrosis. Disruption of cytokine networks may lead to cytokine storm, chronic inflammation, immunosuppression or autoimmune disease.

Why Measure Cytokine Expression in Immune Cells?

Quantifying cytokine expression in immune cells is critically valuable for multiple reasons:

  • Immune activation profiling: Which pathways are triggered by pathogens or inflammatory stimuli? Which immune cell subsets are responding?
  • Biomarker discovery – diagnostics & prognostics: Cytokine signatures (for example elevated IL-6, TNF-α, IFN-γ) often correlate with disease severity, progression, outcome.
  • Therapeutic monitoring: After vaccines, biologics, immunotherapies—changes in cytokine expression among immune cells reflect immune modulation, therapeutic efficacy or side effects.
  • Pathogenesis insight: Many pathogens modulate the host cytokine response to evade or subvert immunity. Measuring cytokines in immune cells reveals these host-pathogen interactions.
  • Transition from inflammation to resolution/tissue repair: Cytokines mark shifts from pro-inflammatory to anti-inflammatory/repair stages (for example IL-10, TGF-β). Assessing cytokines in immune cells helps understand chronic inflammation or delayed resolution.

Sample Sources & Immune Cell Types

For cytokine expression analysis, common sample sources and cell populations include:

  • Peripheral blood mononuclear cells (PBMCs) isolated from whole blood—mixed immune cell population.
  • Sorted immune subsets (CD4⁺ T cells, CD8⁺ T cells, NK cells, monocytes/macrophages, dendritic cells) after flow-cytometric sorting.
  • Stimulated immune cells in culture: e.g., macrophages stimulated with LPS, T lymphocytes with PMA/ionomycin or antigenic peptides—then supernatants or intracellular cytokines measured.
  • Tissue biopsies or lavage fluids (bronchoalveolar lavage, synovial fluid, cerebrospinal fluid) containing immune cells or secreted cytokines.
  • Serum/plasma are often used to infer cytokine secretion by immune cells, though cell‐specific source is less defined.

Each sample type has advantages and caveats: isolation stress may induce artefactual cytokine release; storage or freeze-thaw can degrade cytokines; and cell subset purity, viability, and stimulation conditions must be controlled.

Techniques for Measuring Cytokine Expression in Immune Cells

1. Immunoassays for Protein Quantification (e.g., ELISA)

One of the most common approaches is the enzyme-linked immunosorbent assay (ELISA) for measuring secreted cytokines in supernatants, plasma or serum. Specific capture and detection antibodies allow quantification of individual cytokines (e.g., IL-6, TNF-α).

Strengths: high specificity, quantitative, well-established.

Limitations: often one cytokine per assay; may require relatively large sample volume; cannot delineate which cell type secreted the cytokine unless combined with sorted cells.

2. Multiplex Immunoassays / Bead-Based Arrays

Profiling multiple cytokines simultaneously is beneficial for immune signature discovery. Multiplex platforms (bead-based or membrane arrays) enable concurrent measurement of dozens of cytokines from small sample volumes.

Strengths: high throughput, small sample requirements, broad dynamic range.

Limitations: complexity in assay setup and data analysis; cross-reactivity or signal interference possible; care needed for calibration.

3. Flow Cytometry / Intracellular Cytokine Staining

To measure cytokine expression at the single-cell level and determine which immune subsets are active, flow cytometry is used. After stimulation (e.g., PMA/ionomycin, LPS), cells are fixed, permeabilised and stained for intracellular cytokines (e.g., IFN-γ, IL-4, IL-17) and surface markers (CD4, CD8, CD14, etc.).

Strengths: single-cell resolution, subset specificity, multi-parameter possibility.

Limitations: requires cell stimulation protocols; need to optimise fixation/permeabilisation to preserve cytokine epitopes; requires compensation and gating expertise.

4. Transcriptomic Methods: qPCR, RNA-Seq, Single-Cell RNA-Seq

mRNA levels of cytokines (IL6, TNFA, IFNG, IL1B etc) in immune cells can be quantified by RT-qPCR or next-generation sequencing (RNA-Seq, single-cell RNA-Seq). These capture transcriptional regulation prior to secretion.

Strengths: sensitive, capable of detection even when protein is undetectable; single-cell RNA-Seq provides rich detail across populations.

Limitations: mRNA may not correlate directly with protein secretion; requires bioinformatics for data processing; cost is higher for large studies.

5. Emerging/Advanced Techniques

Modern biotech advances are enabling more refined cytokine detection:

  • Digital ELISA (ultra-sensitive femtogram detection)
  • Mass cytometry (CyTOF) enabling 40+ parameter cytokine and cell-marker profiling per cell
  • Microfluidic immunoassays for single-cell cytokine release
  • Spatial transcriptomics/proteomics to locate cytokine-producing immune cells in tissues

These techniques are promising for immune-profiling during infection/inflammation with high resolution and sensitivity.

Experimental Workflow & Best Practices

  1. Sample collection and immune cell isolation: Use standardised protocols (e.g., Ficoll density centrifugation for PBMCs) to minimise activation artefacts. Keep cells on ice when feasible. Avoid long delays between collection and processing.
  2. Cell stimulation (if required): For intracellular cytokine staining or supernatant assays, select appropriate stimuli (e.g., LPS for monocytes; PMA/ionomycin for T cells; pathogen-derived antigen for adaptive responses). Include unstimulated controls and viability controls.
  3. Normalization and controls: For secreted cytokines, normalise to cell number or total protein. For intracellular flow assays, include viability dye, isotype controls and gating strategy. For transcript assays, select stable housekeeping genes and consider spike-in controls.
  4. Assay selection and optimisation: Based on your research question: need few cytokines vs many? Need cell-subset specificity? Need secreted protein vs transcript? Choose accordingly: ELISA, multiplex, flow cytometry, qPCR/RNA-Seq. Validate capture/detection reagents and run pilot samples.
  5. Data analysis: For protein assays compute absolute concentrations or fold-changes; for transcript assays compute relative expression (e.g., ΔΔCt in qPCR). Use appropriate statistical tests (t-test, ANOVA) when comparing conditions. Visualise via heatmaps, clustering or principal component analysis when many cytokines are profiled.
  6. Biological interpretation: Be cautious—cytokine levels reflect production, secretion, receptor binding, and clearance. Intracellular staining reflects potential production; secreted cytokines reflect cumulative release. mRNA levels may not strictly track protein secretion. Time-course studies are helpful to capture kinetics.
  7. Integration with other data: Combining cytokine expression data with other read-outs (immune cell phenotype by flow cytometry, transcriptomics, proteomics, functional assays) enables deeper immune-signature profiling rather than relying on single cytokines.
  8. Technical caveats: Cytokines can be low abundance, rapidly secreted and degraded, and often act locally. Sample handling, storage conditions, freeze-thaw cycles affect results. Also immune-cell heterogeneity means bulk measurements may obscure subset‐specific effects. Single-cell methods help mitigate this.

Applications & Case Examples

  • Infectious disease research: In viral or bacterial infection, measuring cytokine expression in immune cells (e.g., T cells, monocytes) helps determine immune activation, exhaustion, cytokine‐storm potential and pathogen‐specific responses.
  • Inflammatory and autoimmune disease: Characterising immune cell cytokine profiles (e.g., Th17 vs Treg via IL-17 and IL-10) helps stratify patients, assess disease activity (e.g., rheumatoid arthritis, lupus) and monitor responses to biologics.
  • Vaccine responses: Measuring antigen-stimulated T cell cytokine production (IFN-γ, IL-2, IL-4) helps evaluate Th1/Th2 polarisation, correlates of protection and immunogenicity.
  • Cancer immunotherapy: Monitoring cytokine expression by immune effector cells (e.g., tumour‐infiltrating lymphocytes, NK cells) pre and post checkpoint inhibitor or CAR-T therapy can provide biomarkers of response or immune-related adverse events.
  • Translational biomarker discovery: By combining cytokine expression profiles with clinical outcomes (disease severity, survival, therapeutic response), immune-signatures become potential predictive or prognostic biomarkers.

Summary & Recommendations

Measuring cytokine expression in immune cells during infection or inflammation is a powerful approach to understand immune regulation, disease mechanisms and therapeutic responses. To summarise:

  • Choose your sample type and immune subset carefully to match your research question.
  • Select appropriate detection method (ELISA, multiplex, flow cytometry, transcriptomics) based on analyte number, sensitivity, cell-subset resolution, sample volume and cost.
  • Include proper controls, time courses and normalisation strategies.
  • Interpret cytokine data in context—cell type, stimulus, time, secretion vs transcript vs intracellular.
  • When possible, combine cytokine measurements with other immune-profiling modalities for richer insight.
  • Use validated reagents (such as those from Gentaur) to enhance reproducibility and confidence in results.

By implementing these best practices and choosing appropriate methods, investigators can generate robust cytokine expression data that enhance understanding of immune responses during infection and inflammation, support biomarker discovery, refine therapeutic strategies and drive translational applications.

in News